{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:35:56Z","timestamp":1791192956824,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 AI047367"],"award-info":[{"award-number":["R37 AI047367"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI96882 (CMW), R01 AI070101 and R21 AI11837 (AG)"],"award-info":[{"award-number":["R01 AI96882 (CMW), R01 AI070101 and R21 AI11837 (AG)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yerkes National Primate Center","award":["P510D011132"],"award-info":[{"award-number":["P510D011132"]}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.coi.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T13:45:26Z","timestamp":1438436726000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?"],"prefix":"10.1016","volume":"35","author":[{"given":"Christopher M","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Grakoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2015.06.010_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.coi.2015.06.010_bib0260","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2015.06.010_sbref0270","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2015.06.010_bib0275","first-page":"537","article-title":"Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002\u20132009","volume":"60","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2015.06.010_bib0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tim.2013.09.008","article-title":"Treatment as prevention and cure towards global eradication of hepatitis C virus","volume":"21","author":"Hagan","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coi.2015.06.010_sbref0285","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2010.05.077","article-title":"Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins","volume":"139","author":"Dahari","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2015.06.010_bib0295","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0300","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C Virus into 7 genotypes and 67 subtypes: updated criteria and assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0305","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0310","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2013.05.007","article-title":"Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice","volume":"145","author":"Akazawa","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2015.06.010_sbref0320","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0325","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coi.2015.06.010_bib0330","first-page":"49","article-title":"Animal models for hepatitis C","volume":"369","author":"Billerbeck","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coi.2015.06.010_bib0335","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coi.2015.06.010_bib0340","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coi.2015.06.010_bib0345","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2015.06.010_bib0350","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","article-title":"Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein","volume":"93","author":"Farci","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.010_bib0355","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2015.06.010_bib0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0365","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0370","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/infdis\/173.4.822","article-title":"Effect of immune globulin on the prevention of experimental hepatitis C virus infection","volume":"173","author":"Krawczynski","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2015.06.010_bib0375","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0380","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0385","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0390","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0395","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.010_bib0400","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2015.06.010_bib0405","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_bib0410","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.010_bib0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell\u2013cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1099\/vir.0.006700-0","article-title":"CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells","volume":"90","author":"Witteveldt","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coi.2015.06.010_bib0425","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2015.06.010_bib0430","doi-asserted-by":"crossref","first-page":"e59776","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2015.06.010_sbref0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2015.06.010_bib0440","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2014.00274","article-title":"Protective immunity against hepatitis C: many shades of gray","volume":"5","author":"Abdel-Hakeem","year":"2014","journal-title":"Front Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.coi.2015.06.010_bib0445","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/infdis\/jis762","article-title":"Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies","volume":"207","author":"Lauer","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2015.06.010_bib0450","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.010_sbref0455","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0460","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.coi.2015.06.010_bib0465","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2012.06.005","article-title":"Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus","volume":"143","author":"Park","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coi.2015.06.010_sbref0470","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2015.06.010_sbref0475","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2015.06.010_bib0480","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.21319","article-title":"CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus","volume":"44","author":"Puig","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0485","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.03574-13","article-title":"Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses","volume":"88","author":"Chmielewska","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2015.06.010_sbref0490","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.coi.2015.06.010_sbref0495","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.27278","article-title":"T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee","volume":"60","author":"Callendret","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.coi.2015.06.010_bib0500","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/nm.3408","article-title":"Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection","volume":"19","author":"Park","year":"2013","journal-title":"Nat Med"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791515000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791515000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:31:51Z","timestamp":1760603511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791515000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"alternative-id":["S0952791515000916"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2015.06.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726359655.793519331","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.726359655.793518519","asserted-by":"object"}]},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}